Combined ’Test and Treat’ Campaigns for HIV, Hepatitis B and Hepatitis C

Over 39 million individuals are living with HIV, 296 million with chronic hepatitis B (HBV) and 58 million with chronic hepatitis C (HCV). Despite successful treatments for these blood-borne viruses, over 1.7 million people die per annum. To combat this, the World Health Organization (WHO) recommended implementing triple testing for HIV, HBV and HCV.

A systematic review, published in Open Forum Infectious Diseases, provided evidence for this policy, by identifying the prevalence of these blood-borne viruses, and discussing the costs of available triple tests.

The full review can be accessed here.